Cargando…
Low-Cost, Large-Scale Production of the Anti-viral Lectin Griffithsin
Griffithsin, a broad-spectrum antiviral lectin, has potential to prevent and treat numerous viruses including HIV, HCV, HSV, SARS-CoV, and SARS-CoV-2. For these indications, the annual demand for Griffithsin could reach billions of doses and affordability is paramount. We report the lab-scale valida...
Autores principales: | Decker, John S., Menacho-Melgar, Romel, Lynch, Michael D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7471252/ https://www.ncbi.nlm.nih.gov/pubmed/32974328 http://dx.doi.org/10.3389/fbioe.2020.01020 |
Ejemplares similares
-
Integrated autolysis, DNA hydrolysis and precipitation enables an improved bioprocess for Q-Griffithsin, a broad-spectrum antiviral and clinical-stage anti-COVID-19 candidate
por: Decker, John S., et al.
Publicado: (2022) -
Technoeconomic Modeling of Plant-Based Griffithsin Manufacturing
por: Alam, Aatif, et al.
Publicado: (2018) -
Bulk production of the antiviral lectin griffithsin
por: Fuqua, Joshua L., et al.
Publicado: (2015) -
In Preparation for Outdoor Pharming: Griffithsin Can Be Expressed in Nicotiana excelsiana and Retains Activity After Storage as Silage
por: Eapen, Paul, et al.
Publicado: (2020) -
Griffithsin: An Antiviral Lectin with Outstanding Therapeutic Potential
por: Lusvarghi, Sabrina, et al.
Publicado: (2016)